Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1

3(50.0%)

N/A

2(33.3%)

Phase 4

1(16.7%)

6Total

Phase 1(3)

N/A(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03907384Not ApplicableCompleted

Mat Pilates and Vascular Function in Obese Females

Role: collaborator

NCT02882672Phase 1Completed

Changes in Adiponectin and Cardiovascular Disease Risk Factors in Overweight Patients

Role: lead

NCT02882724Phase 1Completed

Changes in Speed, Endurance and Balance in Women Patients With Multiple Sclerosis After 4 & 8 Weeks of Aquatic Exercise Training

Role: lead

NCT02876627Phase 1Completed

Effect Aerobic Training on Women With Breast Cancer After Chemotherapy

Role: lead

NCT02493699Not ApplicableCompleted

Martial Arts Therapy in Autism Spectrum Disorders

Role: lead

NCT01546090Phase 4Completed

Effect of Alprazolam on the Success of Inferior Alveolar Nerve (IAN) Block

Role: collaborator

All 6 trials loaded